Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Devoe

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Case Reports in Oncological Medicine|August 31, 2019
Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous CarcinomaNarayanan Sadagopan, Craig Devoe
Expert Opinion on Drug Safety|March 9, 2016
BRAF inhibitors - do we need to worry about kidney injury?Rimda Wanchoo, Craig Devoe, Kenar D Jhaveri
Pancreas (Fairfax, Va.)|February 8, 2020
Why HALO 301 Failed and Implications for Treatment of Pancreatic CancerNausheen Hakim, Rajvi Patel, Craig Devoe, et al.
Archives of Endocrinology and Metabolism|September 3, 2015
PEG-asparaginase induced severe hypertriglyceridemiaRodolfo J Galindo, Justin Yoon, Craig Devoe, et al.
Lung Cancer Management|June 4, 2021
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancerJames Newman, Isabel Preeshagul, Nina Kohn, et al.
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Carfilzomib-related acute kidney injuryKenar D Jhaveri, Shailaja Chidella, Jeny Varghese, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 22, 2022
Inpatient utilization of immune checkpoint inhibitors and clinical outcomesJonathan Wang, Chung-Shien Lee, Shirin Attarian, et al.
Leukemia & Lymphoma|April 21, 2016
Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancerGabor Oroszi, Judith Brody, Tianyu Yang, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Leukemia & Lymphoma|October 25, 2021
The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patientsCristina M Ghiuzeli, Miroslav Stýblo, Jesse Saunders, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Case Reports in Oncological Medicine|August 31, 2019
Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous CarcinomaNarayanan Sadagopan, Craig Devoe
Expert Opinion on Drug Safety|March 9, 2016
BRAF inhibitors - do we need to worry about kidney injury?Rimda Wanchoo, Craig Devoe, Kenar D Jhaveri
Pancreas (Fairfax, Va.)|February 8, 2020
Why HALO 301 Failed and Implications for Treatment of Pancreatic CancerNausheen Hakim, Rajvi Patel, Craig Devoe, et al.
Archives of Endocrinology and Metabolism|September 3, 2015
PEG-asparaginase induced severe hypertriglyceridemiaRodolfo J Galindo, Justin Yoon, Craig Devoe, et al.
Lung Cancer Management|June 4, 2021
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancerJames Newman, Isabel Preeshagul, Nina Kohn, et al.
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Carfilzomib-related acute kidney injuryKenar D Jhaveri, Shailaja Chidella, Jeny Varghese, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 22, 2022
Inpatient utilization of immune checkpoint inhibitors and clinical outcomesJonathan Wang, Chung-Shien Lee, Shirin Attarian, et al.
Leukemia & Lymphoma|April 21, 2016
Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancerGabor Oroszi, Judith Brody, Tianyu Yang, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Leukemia & Lymphoma|October 25, 2021
The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patientsCristina M Ghiuzeli, Miroslav Stýblo, Jesse Saunders, et al.
Pageof 2